Abstract:Objective To explore the efficacy of escitalopram combined with low frequency repetitive transcranial magnetic stimulation and psychological intervention in the treatment of generalized anxiety. Methods A total of 88 patients with generalized anxiety admitted to our hospital from April 2018 to May 2019, and randomly divided into the observation group (n = 44) and the control group (n = 44). The control group was treated with escitalopram and psychological intervention. The observation group was treated with low frequency repetitive transcranial magnetic stimulation on the basis of the control group. After 8 weeks, the therapeutic effects of the two groups were compared. The differences of hamilton anxiety scale (HAMA) and selfrating anxiety scale (SAS) scores before and after treatment were observed. The changes of treatment emergent symptom scale (TESS) scores at 1, 3, 5 and 8 weeks after treatment were observed. Results After treatment, the improvement rate of the anxiety state of the observation group was 95.45%, which was higher than that of the control group (79.55%) (P < 0.05). The difference of HAMA score and SAS score before and after treatment was statistically significant between the two groups (P < 0.05). After treatment for 1, 3, 5 and 8 weeks, the TESS scores of the observation group and the control group were compared, and the analysis of variance of repeated measurement design was used. ① The TESS scores of the observation group and the control group were different during different time periods (P < 0.05). ② The TESS scores of the observation group and the control group were different after treatment (P < 0.05), and the TESS scores of the observation group and the control group were lower. ③ The trend of TESS scores between the observation group and the control group was different (P < 0.05). Conclusions Escitalopram combine with low-frequency repetitive transcranial magnetic stimulation and psychological intervention has significant effect on generalized anxiety, which can effectively relieve anxiety such as tension and restlessness. After taking the medicine, there are few adverse conditions, relatively safe, and then improve the compliance of patients, which has a certain clinical promotion value.